Influence of Glucocorticoids on Cellular Senescence Hallmarks in Osteoarthritic Fibroblast-like Synoviocytes

Osteoarthritis (OA) is recognized as being a cellular senescence-linked disease. Intra-articular injections of glucocorticoids (GC) are frequently used in knee OA to treat synovial effusion but face controversies about toxicity. We investigated the influence of GC on cellular senescence hallmarks and senescence induction in fibroblast-like synoviocytes (FLS) from OA patients and mesenchymal stem cells (MSC). Methods: Cellular senescence was assessed via the proliferation rate, β-galactosidase staining, DNA damage and CKI expression (p21, p16INK4A). Experimental senescence was induced by irradiation. Results: The GC prednisolone did not induce an apparent senescence phenotype in FLS, with even higher proliferation, no accumulation of β-galactosidase-positive cells nor DNA damage and reduction in p21mRNA, only showing the enhancement of p16INK4A. Prednisolone did not modify experimental senescence induction in FLS, with no modulation of any senescence parameters. Moreover, prednisolone did not induce a senescence phenotype in MSC: despite high β-galactosidase-positive cells, no reduction in proliferation, no DNA damage and no CKI enhancement was observed. Conclusions: We provide reassuring in vitro data about the use of GC regarding cellular senescence involvement in OA: the GC prednisolone did not induce a senescent phenotype in OA FLS (the proliferation ratio was even higher) and in MSC and did not worsen cellular senescence establishment.

[1]  Zejun Liang,et al.  Targeting cellular senescence prevents glucocorticoid-induced bone loss through modulation of the DPP4-GLP-1 axis , 2021, Signal Transduction and Targeted Therapy.

[2]  G. Ferbeyre,et al.  Osteoclasts protect bone blood vessels against senescence through the angiogenin/plexin-B2 axis , 2021, Nature Communications.

[3]  O. Kosyk,et al.  Prolonged Glucocorticoid Exposure Does Not Accelerate Telomere Shortening in Cultured Human Fibroblasts , 2020, Genes.

[4]  R. Loeser,et al.  Mechanisms and therapeutic implications of cellular senescence in osteoarthritis , 2020, Nature Reviews Rheumatology.

[5]  Seul Gi Kim,et al.  Prednisolone suppresses adriamycin-induced vascular smooth muscle cell senescence and inflammatory response via the SIRT1-AMPK signaling pathway , 2020, PloS one.

[6]  Na Zhang,et al.  Synovial membrane mesenchymal stem cells: past life, current situation, and application in bone and joint diseases , 2020, Stem cell research & therapy.

[7]  S. Gregory,et al.  Synovial cell cross-talk with cartilage plays a major role in the pathogenesis of osteoarthritis , 2020, Scientific Reports.

[8]  D. Baiwir,et al.  Proteins involved in the endoplasmic reticulum stress are modulated in synovitis of osteoarthritis, chronic pyrophosphate arthropathy and rheumatoid arthritis, and correlate with the histological inflammatory score , 2020, Scientific Reports.

[9]  A. Grodzinsky,et al.  DEXAMETHASONE: CHONDROPROTECTIVE CORTICOSTEROID OR CATABOLIC KILLER? , 2019, European cells & materials.

[10]  C. Krettek,et al.  Mesenchymal stem cell senescence alleviates their intrinsic and seno-suppressive paracrine properties contributing to osteoarthritis development , 2019, Aging.

[11]  R. Weinreb,et al.  Cellular and cytoskeletal alterations of scleral fibroblasts in response to glucocorticoid steroids. , 2019, Experimental eye research.

[12]  J. Cintrat,et al.  Glucocorticoids delay RAF-induced senescence promoted by EGR1 , 2019, Journal of Cell Science.

[13]  O. Malaise,et al.  Seno-suppressive molecules as new therapeutic perspectives in rheumatic diseases. , 2019, Biochemical pharmacology.

[14]  R. Menon,et al.  Dexamethasone induces primary amnion epithelial cell senescence through telomere-P21 associated pathway† , 2019, Biology of Reproduction.

[15]  E. Charlier,et al.  CEMIP (KIAA1199) induces a fibrosis-like process in osteoarthritic chondrocytes , 2019, Cell Death & Disease.

[16]  N. Sharpless,et al.  Expression of p16INK 4a is a biomarker of chondrocyte aging but does not cause osteoarthritis , 2018, Aging cell.

[17]  S. Ichinose,et al.  Specific markers and properties of synovial mesenchymal stem cells in the surface, stromal, and perivascular regions , 2018, Stem Cell Research & Therapy.

[18]  S. Melov,et al.  Unmasking Transcriptional Heterogeneity in Senescent Cells , 2017, Current Biology.

[19]  Shenghui He,et al.  Senescence in Health and Disease , 2017, Cell.

[20]  Jeffrey B. Driban,et al.  Effect of Intra-articular Triamcinolone vs Saline on Knee Cartilage Volume and Pain in Patients With Knee Osteoarthritis: A Randomized Clinical Trial , 2017, JAMA.

[21]  J. Elisseeff,et al.  Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment , 2017, Nature Medicine.

[22]  E. Charlier,et al.  Glucocorticoid-induced leucine zipper (GILZ) is involved in glucocorticoid-induced and mineralocorticoid-induced leptin production by osteoarthritis synovial fibroblasts , 2016, Arthritis Research & Therapy.

[23]  Jun Xiao,et al.  Effect of autophagy induced by dexamethasone on senescence in chondrocytes , 2016, Molecular medicine reports.

[24]  Y. Beguin,et al.  Clinical-scale expansion of mesenchymal stromal cells: a large banking experience , 2016, Journal of Translational Medicine.

[25]  S. Kurtz,et al.  The Use of Hyaluronic Acid and Corticosteroid Injections Among Medicare Patients With Knee Osteoarthritis. , 2016, The Journal of arthroplasty.

[26]  E. Charlier,et al.  Selective glucocorticoid receptor modulator compound A, in contrast to prednisolone, does not induce leptin or the leptin receptor in human osteoarthritis synovial fibroblasts. , 2015, Rheumatology.

[27]  C. Kwoh,et al.  Synovitis in knee osteoarthritis: a precursor of disease? , 2014, Annals of the rheumatic diseases.

[28]  C. Manferdini,et al.  Adipose mesenchymal stem cells protect chondrocytes from degeneration associated with osteoarthritis. , 2013, Stem cell research.

[29]  E. Charlier,et al.  Acute-Phase Serum Amyloid A in Osteoarthritis: Regulatory Mechanism and Proinflammatory Properties , 2013, PloS one.

[30]  S. Snelling,et al.  Glucocorticoids induce senescence in primary human tenocytes by inhibition of sirtuin 1 and activation of the p53/p21 pathway: in vivo and in vitro evidence , 2013, Annals of the rheumatic diseases.

[31]  R. E. Hughes,et al.  Glucocorticoids suppress selected components of the senescence‐associated secretory phenotype , 2012, Aging cell.

[32]  M. Malaise,et al.  Genistein induces adipogenesis but inhibits leptin induction in human synovial fibroblasts , 2009, Laboratory Investigation.

[33]  M. Dougados,et al.  EULAR report on the use of ultrasonography in painful knee osteoarthritis. Part 1: Prevalence of inflammation in osteoarthritis , 2005, Annals of the rheumatic diseases.

[34]  M. Merville,et al.  15-Deoxy-Δ12,14-prostaglandin J2 Inhibits Bay 11-7085-induced Sustained Extracellular Signal-regulated Kinase Phosphorylation and Apoptosis in Human Articular Chondrocytes and Synovial Fibroblasts* , 2004, Journal of Biological Chemistry.

[35]  J. MacLeod,et al.  Corticosteroids alter the differentiated phenotype of articular chondrocytes , 2001, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[36]  V. Cristofalo,et al.  Enhanced proliferation of human fibroblasts, in the presence of dexamethasone, is accompanied by changes in p21Waf1/Cip1/Sdi1 and the insulin‐like growth factor type 1 receptor , 1998, Journal of cellular physiology.